Journal article
Transforming growth factor-β impairs glucocorticoid activity in the A549 lung adenocarcinoma cell line
S Salem, T Harris, JSL Mok, MYS Li, CR Keenan, MJ Schuliga, AG Stewart
British Journal of Pharmacology | Published : 2012
Abstract
BACKGROUND AND PURPOSE The lung adenocarcinoma cell line, A549, undergoes epithelial-mesenchymal cell transition (EMT) in response to TGF-β. Glucocorticoids do not prevent the EMT response, but TGF-β induced resistance to the cytokine-regulatory action of glucocorticoids. We sought to characterize the impairment of glucocorticoid response in A549 cells. EXPERIMENTAL APPROACH A549 cells were exposed to TGF-β for up to 96 h before glucocorticoid treatment and challenge with IL-1α to assess glucocorticoid regulation of IL-6 and CXCL8 production. Nuclear localization of the glucocorticoid receptor α (GRα) was ascertained by immunofluorescence and Western blotting. Transactivation of the glucocor..
View full abstractRelated Projects (1)
Grants
Awarded by NHMRC
Funding Acknowledgements
These studies were supported by a project grant from NHMRC 628691.